Furthermore, activation of NRF2 restricted only to muscle can lead to resistance to obesity and diabetes (Uruno et al., 2016; Matzinger et al., 2018), suggesting that metabolic consequences of NRF2 activation by genetics versus pharmacological tools differ across the tissues. Here, NFE2L2 is linked to obesity disorder.